Glycopyrrolate Injection
Product Images NDC 71872-7179

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7179-1 Pdp (71872 7179 1)

This is a description of Glycopyrrolate injection, USP that comes in a 20 mL multiple-dose vial with 4 mg/20 mL strength, lot # XXXX, and expiration date XX/XXXX. It is not for use in newborns and contains benzyl alcohol for intravenous or intramuscular use. It is adjusted, if necessary, with pH and sodium or hydrochloric acid. The usual dosage can be found in the package insert. It needs to be stored at 20 ° to 25 ° C. It's marketed by Sandoz Inc. and the manufacturer NDC is 00781-3831-85, and it's a product of Italy. It's repackaged by Medical Purchasing Solutions located in Scottsdale, AZ 85260.*

FDA Label Image

Chemical-structure (Glycopyrrolate Injection 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.